Cystic fibrosis year in review 2019: Section 2 pulmonary disease and infections.
Adrienne P SavantSusanna A McColleyPublished in: Pediatric pulmonology (2020)
During the year 2019, research and case reports or series in the field of cystic fibrosis (CF) were in abundance. To adequately address the large body of CF research published during 2019, the CF year in review will be divided into three sections. This report is the second section, focusing specifically on new research related to pulmonary disease and infections. Additional sections will concentrate on CF transmembrane conductance regulator modulators and the multisystem effects of CF. It is an exciting time to be providing care for patients and their families with CF with all the exciting new discoveries that will be shared in these reviews.
Keyphrases
- cystic fibrosis
- pseudomonas aeruginosa
- lung function
- end stage renal disease
- pulmonary hypertension
- healthcare
- chronic kidney disease
- ejection fraction
- newly diagnosed
- randomized controlled trial
- systematic review
- case report
- chronic obstructive pulmonary disease
- patient reported outcomes
- patient reported
- health insurance